The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader industry now presents questions about future gains. Generic versions are eroding market share, prompting anxieties that betting on companies closely tied to Viagra's once-dominant influence could be a speculative decisio